Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Finland

 

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Attack on outsourcing could spell trouble for Mehilainen

The recently formed Finnish government's moves against outsourcing spell trouble for big social care providers like Esperi Care, Attendo and Mehilainen, a local source tells us, though a second reckons healthcare service outsourcing might be more at risk.

European dentistry reopens

European dental markets are reopening for business as R numbers drop below 1 across the continent. HBI reviews what the current position is in these key markets and talks to operators in these markets to assess demand.

Teleradiology’s elective volumes crash

Teleradiology providers across Europe have seen volumes crash for elective reads because of the shut down of non-essential work in public hospitals, while emergency reads have been less badly affected. But operators' low fixed costs should mean that profits will hold.

European dental markets “could take years to recover from COVID”

As HBI Intelligence reviews the impact of COVID-19, HBI has been talking to operators and analysts. One EU-based operator says many markets across Europe will struggle to recover once the COVID-19 crisis has passed. Here is his view of where will be worst hit - and where we may see a surprising rebound.

‘There is no deal for private sector to take UK NHS cancer patients’

Cancer companies in the UK do not have a contract with the NHS to take 20,000 public patients, despite an earlier report to the contrary in a UK broadsheet newspaper. Providers tell HBI that they fear that a mass of 'second-wave deaths' and look at how pressure might transform clinical pathways in oncology.

Find Us